The global hand-held surgical instruments market size is expected to reach USD 9.6 billion by 2030 at a 7.3% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, such as; cancer, chronic heart, neurological, orthopedic disorders is the leading factor driving the demand for hand-held surgical instruments market. According to the American Cancer Society, more than 16.9 million Americans with a history of invasive cancer were alive in January 2019.
The increasing geriatric population that is more susceptible to developing these disorders is another factor that is expected to propel market growth over the forecast period. According to the U.S. Census Bureau, there were more than 54 million adults aged 65 and older that lived in the U.S. in 2020. Increasing preference for plastic & reconstructive surgeries is another major factor driving the market growth. Increasing disposable income and the booming medical tourism sector in developing countries is also expected to boost the growth of the hand-held surgical instruments market.
The COVID-19 pandemic led to a significant downfall in overall sales of the hand-held surgical instruments market. Increasing focus on COVID-19-infected patients and postponement of elective surgeries resulted in a reduced number of surgeries being performed, which affected the market negatively. However, due to huge backlog and rise in efforts by the surgeons and healthcare facilities to generate higher revenue and fill in the demand & supply gap has helped the market to recover to great extent. Furthermore, the market represents lucrative opportunities with the world finally being able to combat and recover from the pandemic.
Request a free sample copy or view report summary: Hand-held Surgical Instruments Market Report
The forceps segment held a significant market share in 2022 due to its increasing adoption in a surgical setting
The retractors segment is projected to experience maximum growth over the forecast period due to technological advancements in this segment
The orthopedic surgery segment held the highest market share in 2022 owing increasing incidence of musculoskeletal disorders
The plastic and reconstructive surgery segment is expected to experience the fastest growth over the forecast period as a large number of people are opting for these procedures
The hospitals segment held the largest revenue share in 2022 as the majority of the surgical procedures are performed in this setting
The ambulatory surgical centers segment is expected to experience maximum growth over the forecast period owing to the growing popularity of plastic and reconstructive surgeries, ophthalmic surgeries among others in this setting
North America held the largest share in 2022 owing to the presence of well-established healthcare infrastructure
Asia Pacific is expected to experience the fastest growth rate during the forecast period mainly due to the presence of strong medical tourism and increasing focus on healthcare
Grand View Research has segmented the global hand-held surgical instruments market based on product, application, end-use, and region:
Hand-held Surgical Instruments Product Outlook (Revenue, USD Million, 2017 - 2030)
Forceps
Retractors
Dilators
Graspers
Scalpels
Cannulas
Dermatome
Trocars
Others
Hand-held Surgical Instruments Application Outlook (Revenue, USD Million, 2017 - 2030)
Orthopedic Surgery
Cardiology
Ophthalmology
Wound Care
Audiology
Thoracic Surgery
Urology & Gynecology Surgery
Plastic Surgery
Neurosurgery
Others
Hand-held Surgical Instruments End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Hand-held Surgical Instruments Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
List of Key Players in Hand-held Surgical Instruments Market
Zimmer Biomet
B. Braun Melsungen AG
Integra LifeSciences Corporation
Medtronic, plc.
Smith & Nephew
Zimmer Biomet Holdings
Johnson & Johnson Services, Inc.
Becton, Dickinson and Company
CooperSurgical, Inc.
Thompson Surgical Instruments Inc.
Aspen Surgical
"The quality of research they have done for us has been excellent..."